Liliane Chamas
Direktor/Vorstandsmitglied bei Credo Therapies Ltd.
Aktive Positionen von Liliane Chamas
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Private Equity Investor | 01.12.2019 | - |
Amber Therapeutics Ltd.
 Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amber Therapeutics Ltd. is a British company that develops intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology. The company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2020 by Aidan Harold Winston Crawley. Aidan Harold Winston Crawley has been the CEO since 2020. | Direktor/Vorstandsmitglied | 18.06.2021 | - |
Credo Therapies Ltd.
 Credo Therapies Ltd. Financial ConglomeratesFinance Credo Therapies Ltd. is a British dormant company that was founded in 2022. | Direktor/Vorstandsmitglied | 05.12.2022 | - |
Karriereverlauf von Liliane Chamas
Ausbildung von Liliane Chamas
| Concordia University | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Kanada | 2 |
Operativ
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Finance | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Finance |
Amber Therapeutics Ltd.
Amber Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Amber Therapeutics Ltd. is a British company that develops intelligent bioelectrical therapies that can adapt, respond and learn from each person's individual physiology. The company is based in London, UK. and has subsidiaries in United Kingdom. The company was founded in 2020 by Aidan Harold Winston Crawley. Aidan Harold Winston Crawley has been the CEO since 2020. | Health Technology |
Credo Therapies Ltd.
Credo Therapies Ltd. Financial ConglomeratesFinance Credo Therapies Ltd. is a British dormant company that was founded in 2022. | Finance |
- Börse
- Insiders
- Liliane Chamas
- Erfahrung
